Engineering and Development

Management and Executive

Product Management

Sales

Co-Founder and President

Chairman and Chief Technology Officer

STAT+: Up and down the ladder: The latest comings and goings

Adial Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04

EXCLUSIVE: Adial Pharmaceuticals Lead Candidate For Alcohol Use Disorder Advances Toward Phase 3 Trial

Principal Biostatistician FSP - Clinical Development

Cytel is seeking a Principal Biostatistician to support or lead Phase I-III clinical studies, particularly in the Neurology therapeutic area. The role involves providing statistical support, developing study protocols, and preparing clinical study reports while utilizing advanced statistical methods.

Sign up with Google

Sign in with Google